SCHEMBL4876512

SCHEMBL4876512

O=C(O)CNc1ccc(Cl)cc1Oc1ccc(C=NNO)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.43
MAPK1 P28482 2/20 0.43
HPGD P15428 2/20 0.42
LMNA P02545 2/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.41
ALDH1A1 P00352 5/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
GAA P10253 3/20 0.40
POLB P06746 3/20 0.40
HTT P42858 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CHRM1 P11229 1/20 0.40
TDP1 Q9NUW8 2/20 0.40
TSHR P16473 1/20 0.39
TTR P02766 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2398358 0.78 TDP1 (0.46) MAPTHPGDLMNAALDH1A1MEN1
SCHEMBL2392872 0.77 SLC6A4 (0.52) MAPTPTGDR2ALDH1A1MEN1KMT2A
SCHEMBL4876505 0.76 TTR (0.43) MAPTHPGDPTGDR2ALDH1A1GAA
SCHEMBL2392884 0.75 PTGDR2 (0.55) PTGDR2CHRM1TDP1TSHRCYP1A2
SCHEMBL2394816 0.74 PTGDR2 (0.55) MAPTPTGDR2ALDH1A1POLBCHRM1
SCHEMBL2395017 0.73 TDP1 (0.40) MAPTHPGDLMNAPTGDR2ALDH1A1
SCHEMBL2393261 0.73 CHRM1 (0.43) HPGDPTGDR2KMT2AGAAHTT
SCHEMBL2394476 0.72 TDP1 (0.42) MAPTPTGDR2ALDH1A1MEN1KMT2A
SCHEMBL2395704 0.71 P2RY1 (0.55) MAPTMAPK1LMNAALDH1A1MEN1
SCHEMBL24460022 0.70 ALDH1A1 (0.57) MAPTHPGDLMNAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080114002-A1 Substituted Acids for the Treatment of Respiratory Diseases ASTRAZENECA AB (SE) 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114002-A1 Substituted Acids for the Treatment of Respiratory Diseases HRH2, HRH1, HRH4 MAPT 3453/4885MAPK1 3620/4885HPGD 700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.